<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&ev=PageView&noscript=1">
Blog

Compliance In Focus

remote services

LEARN MORE ABOUT REMOTE SERVICES

Keep Your Clinical Trial Moving from a Distance

You want to keep your trial on track, but physical distancing and travel restrictions have made it difficult. Fortunately, IMARC has experience providing remote services.

FILTER BY:

Newest Post

Posted by Toni Hegyi on Thu, Nov 14, 2019

Answers to Your GCP Questions Made a Little Easier

No matter where you land on the clinical research spectrum, chances are you have encountered some challenges with interpreting and/or implementing Good Clinical Practice (GCP) guidelines. With so many trial designs and research settings, it can be difficult to know how to appropriately apply GCP and even more difficult at times to get answers.

To help with your search, the FDA has created a page that provides copies of e-mail messages (the original inquiry and associated reply(ies)) that have been submitted by the public to the Good Clinical Practice Program’s [email protected] e-mail account. Inquiries range from 2013 to 2018 and are categorized by the following inquiry subjects:

Topics: Good Clinical Practice, GCP, FDA

Posted by John Lehmann on Wed, Mar 14, 2018

What Is New In GCP

Clinical research professionals need to keep up to date with changes to the industry to ensure their studies remain compliant and human subjects are protected as research becomes more complex. Several important changes have taken place over recent years, including greater emphasis on risk-based and quality-focused thinking, as well as the increased use of electronic technologies to accomplish research activities.

Topics: GCP, IMARC Research Whitepaper

Posted by John Lehmann on Thu, Aug 13, 2015

Why Do We Need to Audit?

How is auditing different than monitoring? Why do we need to audit? Since these questions are so often asked, we decided to create a graphic that will help you understand when to consider an audit. In short, auditing brings an independent, quality assurance perspective to the clinical research landscape Investigational sites, sponsors, and vendors benefit from high-level process assessments and improvements. Experienced auditors leverage extensive training to help ensure subject safety, data integrity, and protocol and regulatory compliance.

Topics: GCP, Auditing, Quality Assurance

Posted by John Lehmann on Mon, Nov 06, 2017

Screening or Consent: Which Came First?

 

The informed consent process is arguably one of the most important parts of a clinical research study. From the Principles of ICH GCP: the rights, safety, and well-being of the trial subjects are the most important considerations and should prevail over interests of science and society. Proper informed consent ensures that the patient is aware of the risks and requirements of being in a research study and has voluntarily agreed to participate in research.  The regulations, CFR part 50 also cover the importance, rules and process of informed consent.

Topics: Informed Consent, Research Coordinators, GCP

Posted by John Lehmann on Wed, Mar 04, 2015

GCP… What Does it Mean?

Do you know why rules, regulations and standards exist? What exactly is Good Clinical Practice and how does this help protect patients and data integrity?

Topics: Good Clinical Practice, GCP, Clinical Research

Posted by John Lehmann on Tue, Oct 24, 2017

Why Do We Need to Audit?

How is auditing different than monitoring?  Why do we need to audit?  Since these questions are so often asked, we decided to create a graphic that will help you understand when to consider an audit. In short, auditing brings an independent, quality assurance perspective to the clinical research landscape Investigational sites, sponsors, and vendors benefit from high-level process assessments and improvements. Experienced auditors leverage extensive training to help ensure subject safety, data integrity, and protocol and regulatory compliance.

Topics: Infographic, GCP, IMARC Research, Auditing

Posted by John Lehmann on Wed, Mar 04, 2015

What are Good Documentation Practices?

Whether on the site or sponsor level, in clinical research we are asked to use  Good Documentation Practices (GDP) during the conduct of a clinical trial.  One might assume that a quick visit to the FDA website would produce the list of practices.  However, there is no Code of Federal Regulations for GDP.

Topics: Good Documentation Practices, GCP, FDA

Posted by Brandy Chittester on Wed, Mar 04, 2015

Screening or Consent: Which Came First?

The informed consent process is arguably one of the most important parts of a clinical research study. From the Principles of ICH GCP: the rights, safety, and well-being of the trial subjects are the most important considerations and should prevail over interests of science and society. Proper informed consent ensures that the patient is aware of the risks and requirements of being in a research study and has voluntarily agreed to participate in research.  The regulations, CFR part 50 also cover the importance, rules and process of informed consent.

Topics: CFR Part 50, Informed Consent, GCP, FDA